Statistical Analysis of Health Data for Defensible Clinical Evidence
CLINICAL DATA | RETROSPECTIVE COHORT ANALYSIS | STATISTICAL ANALYSIS & MODELLING
A retrospective study required a structured statistical framework to analyse complex clinical and microbiological data, account for differences in disease severity, and produce clear, publication-oriented evidence.
Wells Research Consultancy supported the project from data preparation and descriptive analysis through regression modelling, clinical risk adjustment, interpretation and manuscript-ready reporting,
-
Client Situation
Complex retrospective data
A retrospective cohort combined clinical, microbiological and patient-outcome data, requiring a clear statistical framework to account for disease severity and support valid clinical interpretation.
-
What Was Done
Clinical data analysis & statistical modelling
Completed data cleaning, descriptive and subgroup analysis, regression modelling and clinical severity adjustment, with statistical outputs developed for manuscript reporting.
-
Outcome
Publication-ready clinical evidence
A structured, risk adjusted analysis with statistical tables, figures and clinically meaningful interpretation, supporting defensible conclusions and peer-reviewed publication.
The Challenge
This retrospective study involved a complex clinical dataset including patient characteristics, microbiological surveillance, infection data, disease severity measures and clinical outcomes. Therefore, the statistical analysis needed to do more than describe the cohort — it had to account for important differences between patients and support clinical interpretation.
- Integrating clinical, microbiological and outcome data within one analytical framework
- Distinguishing colonisation, subsequent infection and clinical outcomes
- Comparing clinically distinct patient subgroups
- Accounting for differences in underlying disease and organ failure severity
- Reducing the risk of misleading conclusions from unadjusted associations
- Selecting statistical methods appropriate to a retrospective cohort study
- Producing results that could be clearly interpreted and reported for publication
Our Approach
1. Structure the analysis around the clinical question
The dataset was reviewed and organised so that clinical characteristics, microbiological surveillance, infection status, disease-severity measures and outcomes could be analysed within one coherent framework. The study design included a retrospective cohort with clinically important subgroup comparisons and multiple severity measures.
2. Build the analysis in stages
The statistical workflow moved from data review and cleaning through descriptive analysis and subgroup comparisons before progressing to regression modelling. This helped ensure that the modelling was informed by the structure of the cohort rather than applied in isolation.
3. Account for clinical severity
Established liver disease and organ failure severity measures were incorporated into the modelling strategy so that relationships between microbiological status and outcomes could be interpreted in the context of underlying patient severity.
4. Translate statistical output into clinical evidence
The final stage focused on interpretation and reporting, including structured statistical outputs, tables, figures and manuscript-ready material designed to support clear clinical interpretation and publication.
The Outcome/Impact
The completed analysis transformed a complex retrospective dataset into a structured, risk-adjusted evidence base that could be interpreted in its clinical context and reported clearly for publication.
By moving beyond unadjusted comparisons and incorporating established measures of disease severity into the modelling strategy, the analysis provided a more defensible basis for interpreting relationships between microbiological status, infection and patient outcomes. The project also produced structured statistical outputs, model interpretations, tables and figures for manuscript development.
Key impact
- Created a clear analytical framework for complex clinical and microbiological data
- Supported clinically meaningful interpretation through regression modelling and severity adjustment
- Produced publication ready statistical outputs for manuscript and peer-review use
- Strengthened the methodological basis for drawing conclusions from retrospective clinical data
-
Why This Matters
Complex data can easily produce misleading conclusions if clinical severity, subgroup differences and outcome definitions are not handled carefully.
In this project, microbiological findings, infection status, disease severity and patient outcomes were closely related. A simple unadjusted comparison would therefore have provided only part of the picture. The statistical analysis needed to reflect the structure of the retrospective cohort and the clinical context in which the data were generated.
By combining structured clinical data analysis with regression modelling and severity adjustment, the project created a stronger basis for interpreting associations and preparing the findings for scientific reporting.
This case study shows why specialist statistical analysis for clinical research is not simply about applying tests to a dataset. It is about choosing an analytical approach that supports credible interpretation, transparent reporting and conclusions that can withstand peer-review scrutiny.